台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

MP06-10: Characteristics of mCRPC patients received Abiraterone acetate plus prednisolone and Enzalutamide before chemotherapy

2022-06-07 • 觀看: 1140 • 回應: 0 • doc
MP06-09: KCGMH experience and meta-analysis: 6-cycle complete rate of Radium-223 therapy in Mcrpc patients with different treatment sequences

2022-06-07 • 觀看: 1063 • 回應: 0 • doc
MP06-08: Treatment strategy and systemic review with PSMA PET/CT scan in progressive advanced prostate cancer

2022-06-07 • 觀看: 1284 • 回應: 0 • doc
MP06-07: Oncological and functional outcomes in high risk and very high risk prostate cancer patients receiving robotic-assisted radical prostatectomy

2022-06-07 • 觀看: 1149 • 回應: 0 • doc
MP06-06: The analysis of concordance rates between cancer stage of MR/US fusion prostate biopsy and radical prostatectomy specimen

2022-06-07 • 觀看: 1095 • 回應: 0 • doc
MP06-05: Retzius-sparing robot-assisted radical prostatectomy and extended pelvic lymph node dissection for very high-risk prostate cancer

2022-06-07 • 觀看: 1122 • 回應: 0 • doc
MP06-04: Hyperforin induces extrinsic/intrinsic apoptosis signaling and inhibits NF-кB for metastasis suppression in prostate cancer cells

2022-06-07 • 觀看: 1240 • 回應: 0 • doc
MP06-03: Real world experience of androgen deprivation therapy associated bone fracture risk in newly diagnosed prostate cancer patients

2022-06-07 • 觀看: 1088 • 回應: 0 • doc
MP06-02: A single center experience of Abiraterone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel based chemotherapy

2022-06-07 • 觀看: 1115 • 回應: 0 • doc
MP06-01: Is extraperitoneal extended pelvic lymph node dissection adequate during robotic assisted radical prostatectomy for intermediate and high risk localized prostate cancer?

2022-06-07 • 觀看: 1083 • 回應: 0 • doc
MP05-10: Thrombospondin-4 induces lymphangiogenesis by lymphatic endothelial cell recruitment in bladder tumor

2022-06-07 • 觀看: 1377 • 回應: 0 • doc
MP05-09: Suppression of tumor characteristics of urothelial carcinoma cells by berberrubine and resveratrol by GSTM2 induction

2022-06-07 • 觀看: 1058 • 回應: 0 • doc

Prev
374
375
376
377
378
379
380
381
382
383
Next
/ 1052